Orchestra BioMed Holdings, Inc.
OBIO
$2.78
$0.207.75%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -16.16M | -15.43M | -15.98M | -13.46M | -12.82M |
| Total Depreciation and Amortization | 84.00K | 76.00K | 74.00K | 74.00K | 72.00K |
| Total Amortization of Deferred Charges | 31.00K | -- | -- | -- | 3.00K |
| Total Other Non-Cash Items | 3.87M | 2.29M | 2.63M | 2.11M | 1.89M |
| Change in Net Operating Assets | -1.36M | -639.00K | 3.07M | -1.83M | -116.00K |
| Cash from Operations | -13.54M | -13.70M | -10.21M | -13.11M | -10.97M |
| Capital Expenditure | -106.00K | -68.00K | -107.00K | -8.00K | 3.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -602.00K | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.05M | 625.00K | 10.53M | 5.87M | 33.15M |
| Cash from Investing | -3.75M | 557.00K | 10.42M | 5.86M | 33.15M |
| Total Debt Issued | 15.00M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -10.85M |
| Issuance of Common Stock | 51.00K | 15.04M | 171.00K | 18.00K | 153.00K |
| Repurchase of Common Stock | -550.00K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -554.00K | -- | -- | -- | 0.00 |
| Cash from Financing | 13.95M | 15.04M | 171.00K | 18.00K | -10.70M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.34M | 1.89M | 389.00K | -7.24M | 11.48M |